Results 271 to 280 of about 1,061,703 (360)

Glomage : A multimodal platform for high-content morphological and RNA profiling of glomeruli in zebrafish and mouse models

Schindler M, Lange T, Bach S, Lienkamp SS, Endlich N.   +4 more
europepmc   +1 more source

Temporal Proteomic Assessment of Glomerular Protocadherin FAT1 in <i>de novo</i> Membranous Nephropathy of the Kidney Allograft. [PDF]

Kidney Int Rep
Batal I, Burke P, Kudose S, Crew RJ, Alexander MP, Sethi S.   +5 more
europepmc   +1 more source

A Delphi consensus project to capture experts' opinion on hyperkalaemia management across the cardiorenal spectrum

ESC Heart Failure, Volume 12, Issue 2, Page 1132-1140, April 2025.
Abstract The main purpose of this project was to capture experts' opinion on hyperkalaemia management and form best practice recommendations for cardiorenal patients in Greece. A steering committee of nephrologists and cardiologists developed 37 statements. An online questionnaire completed by 32 experts in cardiorenal management in Greece.
Christina Chrysohoou, Maria Marketou, Maria Aktsiali, Ioannis Griveas   +3 more
wiley   +1 more source

Effects of Low-Dose Cypermethrin Exposure on the Liver and Kidney of Swiss Albino Mice: Histopathological and Biochemical Insights. [PDF]

Vet Med Sci
Kundu SK, Sayeed A, Shanta SA, Tanny BR, Khatun P, Kundu SR, Rocky ZH, Maruf MAA, Bhattacharjee B, Basu T.   +9 more
europepmc   +1 more source

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension

ESC Heart Failure, Volume 12, Issue 2, Page 1416-1426, April 2025.
Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr, Stanislav Keranov, Paulina van Wickern, Holger Nef, Christian Hamm, Pascal Bauer, Christian Troidl, Samuel Sossalla, Sandra Voss, Christoph Liebetrau, Manuel J. Richter, Henning Gall, Werner Seeger, Ardeschir Ghofrani, Athiththan Yogeswaran, Khodr Tello   +15 more
wiley   +1 more source

Hemodynamic simulation and <i>in vitro</i> modeling of three-dimensional glomeruli at anatomical scale. [PDF]

Phys Fluids (1994)
Kim DA, Armenta A, Vaughan JC, Terasaki M, Himmelfarb J, Zheng Y.   +5 more
europepmc   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

IgA Nephropathy Associated Hypertensive Retinopathy and Purtscher-Like Retinopathy. [PDF]

J Vitreoretin Dis
Çevik TS, Kocaman Ata S, Özdamar Erol Y, Eser EP.   +3 more
europepmc   +1 more source

Mid‐term survival in patients awaiting heart and kidney transplantation with Impella 5.5 support

ESC Heart Failure, EarlyView.
Abstract Background Patients with end‐stage heart failure and chronic kidney disease requiring dual‐organ transplantation (DOT) face significant challenges in utilizing durable mechanical circulatory support due to the risks associated with renal replacement therapies (RRTs) and multi‐organ failure.
Smruti Desai, Smit Paghdar, Jose Ruiz, Ji‐Min Jang, Sharan Malkani, Daniel S. Yip, Juan Leoni, Jose Nativi, Basar Sareyyupoglu, Kevin Landolfo, Si Pham, Parag Patel, Rohan Goswami   +12 more
wiley   +1 more source

Hepatitis C Virus (HCV) Recurrence and Death After Viral Clearance in an HCV-Viremic Donor to HCV-Negative Kidney Recipient. [PDF]

Kidney Med
He S, Tanaka T, Kim SH, Thomsen D, Katz DA, Thomas CP, Rastogi P, Aziz H, Reed AI.   +8 more
europepmc   +1 more source